Glucotrack (GCTK) Total Liabilities (2010 - 2025)

Glucotrack has disclosed Total Liabilities across 16 years of filings, most recently posting $5.0 million for Q4 2025.

• Quarterly Total Liabilities fell 73.54% year-over-year to $5.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.0 million (down 73.54% YoY) and the FY2025 annual result came in at $5.0 million, down 73.54% from the prior year.
• Total Liabilities declined to $5.0 million in Q4 2025, from $5.5 million in the prior quarter.
• Over five years, Total Liabilities peaked at $18.9 million in Q4 2024 and troughed at $1.1 million in Q4 2021.
• A 5-year average of $3.1 million and a median of $1.6 million in 2021 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2024 — Total Liabilities surged 1008.43% — and 2025, when it tumbled 73.54%.
• Tracing GCTK's Total Liabilities over 5 years: stood at $1.1 million in 2021, then rose by 8.83% to $1.2 million in 2022, then soared by 41.39% to $1.7 million in 2023, then jumped by 1008.43% to $18.9 million in 2024, then slumped by 73.54% to $5.0 million in 2025.
• Business Quant data shows GCTK's Total Liabilities at $5.0 million in Q4 2025, $5.5 million in Q3 2025, and $3.3 million in Q2 2025.